Showing results (101-110 of 927) with videos related to

Sort By:
Pageof 93
The Lancet. Diabetes & Endocrinology|January 12, 2020
The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trialHertzel C Gerstein, Robert Hart, Helen M Colhoun, et al.
The Lancet. Diabetes & Endocrinology|January 31, 2020
Type 1 diabetes-early life origins and changing epidemiologyJill M Norris, Randi K Johnson, Lars C Stene
The Lancet. Diabetes & Endocrinology|December 4, 2018
Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective studyElizabeth J Samelson, Kerry E Broe, Hanfei Xu, et al.
The Lancet. Diabetes & Endocrinology|January 21, 2020
Alcohol and illicit drug use in people with diabetesAdam Pastor, Jennifer Conn, Richard J MacIsaac, et al.
The Lancet. Diabetes & Endocrinology|November 27, 2018
Systemic effects of periodontitis treatment in patients with type 2 diabetes: a 12 month, single-centre, investigator-masked, randomised trialFrancesco D'Aiuto, Nikolaos Gkranias, Devina Bhowruth, et al.
The Lancet. Diabetes & Endocrinology|June 7, 2025
Once‑weekly IcoSema versus once‑weekly insulin icodec in type 2 diabetes management (COMBINE 1): an open‑label, multicentre, treat‑to‑target, randomised, phase 3a trialChantal Mathieu, Francesco Giorgino, Sin Gon Kim, et al.
The Lancet. Diabetes & Endocrinology|June 7, 2025
Once-weekly IcoSema versus multiple daily insulin injections in type 2 diabetes management (COMBINE 3): an open-label, multicentre, treat-to-target, non-inferiority, randomised, phase 3a trialLiana K Billings, Francesco Andreozzi, Marie Frederiksen, et al.
The Lancet. Diabetes & Endocrinology|June 19, 2025
Re-evaluating the concept of remission in type 2 diabetes: a call for patient-centric approachesKamlesh Khunti, Dimitris Papamargaritis, Vanita R Aroda, et al.
The Lancet. Diabetes & Endocrinology|July 3, 2025
Effects of retatrutide on body composition in people with type 2 diabetes: a substudy of a phase 2, double-blind, parallel-group, placebo-controlled, randomised trialTamer Coskun, Qiwei Wu, Nanette C Schloot, et al.
The Lancet. Diabetes & Endocrinology|December 18, 2025
11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050Irini Genitsaridi, Paraskevi Salpea, Agus Salim, et al.
Pageof 93